WallStreetZenWallStreetZen

NASDAQ: TCRT
Alaunos Therapeutics Inc Stock Ownership - Who owns Alaunos Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Alaunos Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Kevin S. Boyle Sr.Chief Executive Officer2023-09-0168,014$0.14
$9.52kSell

1 of 1

TCRT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TCRT insiders and whales buy or sell their stock.

TCRT Shareholders

What type of owners hold Alaunos Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Msd Partners LP94.62%15,151,516$20.00MInstitution
Randal J. Kirk69.05%11,056,069$14.59MInsider
Robert W. Postma65.59%10,502,592$13.86MInsider
Vanguard Group Inc58.95%9,438,762$12.46MInstitution
Discovery Capital Management LLC24.99%4,001,856$5.28MInstitution
Blackrock Inc20.84%3,336,911$4.40MInstitution
Essex Woodlands Health Ventures Fund Vi L P14.81%2,371,642$3.13MInsider
Geode Capital Management LLC14.09%2,256,351$2.98MInstitution
Jaime Vieser12.93%2,070,321$2.73MInsider
Laurence James Neil Cooper11.24%1,799,280$2.38MInsider

1 of 3

TCRT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TCRT53.36%46.64%Net Selling
RNXT1.96%20.25%Net Buying
AIM8.32%9.92%Net BuyingNet Buying
SYBX3.98%96.02%Net SellingNet Selling
MEIP17.91%82.09%Net Buying
View Top Biotech Stocks

Alaunos Therapeutics Stock Ownership FAQ

Who owns Alaunos Therapeutics?

Alaunos Therapeutics (NASDAQ: TCRT) is owned by 256.68% institutional shareholders, 224.39% Alaunos Therapeutics insiders, and 0.00% retail investors. Randal J. Kirk is the largest individual Alaunos Therapeutics shareholder, owning 11.06M shares representing 69.05% of the company. Randal J. Kirk's Alaunos Therapeutics shares are currently valued at $14.59M.

If you're new to stock investing, here's how to buy Alaunos Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.